Nektar Therapeutics (NASDAQ:NKTR – Free Report) – Analysts at HC Wainwright issued their Q1 2025 earnings per share (EPS) estimates for shares of Nektar Therapeutics in a research note issued to investors on Tuesday, December 10th. HC Wainwright anal
Nektar Therapeutics (NASDAQ:NKTR – Free Report) – Analysts at HC Wainwright issued their Q1 2025 earnings per share (EPS) estimates for shares of Nektar Therapeutics in a research note issued to inve… [+3159 chars]